![Feng Lin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Feng Lin
Directeur Technique/Scientifique/R&D chez THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Fortune : 62 000 $ au 30/06/2024
Profil
Feng Lin is currently the Chief Scientific Officer at Therapeutic Solutions International, Inc. He previously worked as the Director of Chinese Operations at Medistem, Inc. from 2012 to 2014, Senior Scientist at Inovio Pharmaceuticals, Inc. from 2007 to 2012, and Associate at Sanford Burnham Prebys Medical Discovery Institute from 1999 to 2005.
He was also the Chief Scientific Officer at SuperView Biotechnology Co. Ltd.
from 2014 to 2019.
Dr. Lin has a doctorate degree from Central South University, which he received in 1998, as well as a graduate degree and an undergraduate degree from the same university, which he received in 1994 and 1990, respectively.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
31/12/2023 | 62 000 000 ( 1,35% ) | 62 000 $ | 30/06/2024 |
Postes actifs de Feng Lin
Sociétés | Poste | Début |
---|---|---|
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Directeur Technique/Scientifique/R&D | 03/09/2019 |
Anciens postes connus de Feng Lin
Sociétés | Poste | Fin |
---|---|---|
SuperView Biotechnology Co. Ltd. | Directeur Technique/Scientifique/R&D | 01/08/2019 |
MEDISTEM INC | Corporate Officer/Principal | 01/05/2014 |
INOVIO PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2012 |
Sanford Burnham Prebys Medical Discovery Institute
![]() Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 01/12/2005 |
RIVULET MEDIA, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Feng Lin
Central South University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
ENTEST GROUP, INC. | Finance |
INOVIO PHARMACEUTICALS, INC. | Health Technology |
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Rivulet Media, Inc.
![]() Rivulet Media, Inc. Data Processing ServicesTechnology Services Rivulet Media, Inc. engages in in the business of producing, distributing, and marketing feature-length films, television series and mini-series, and television movies from initial creative development through principal photography, postproduction, distribution, and ancillary sales, as well as the music production and distribution industry. The firm is also involved in providing event-based audio and video design, production, and installation services. The company was founded on October 6, 1998 and is headquartered in Gilbert, AZ. | Technology Services |
Medistem, Inc.
![]() Medistem, Inc. Medical SpecialtiesHealth Technology Medistem, Inc. is focused on developing therapies for treating serious diseases and conditions using the natural regenerative properties of stem cells. Endometrial Regenerative Cell possess specialized abilities to stimulate new blood vessel growth and can differentiate into lung, liver, heart, brain, bone, cartilage, fat and pancreatic tissue. The company was founded by Neil H. Riordan in October 2005, and is headquartered in San Diego, CA. | Health Technology |
SuperView Biotechnology Co. Ltd. | |
Sanford Burnham Prebys Medical Discovery Institute
![]() Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Health Services |